Closet- what intrigues me the most is you differ in opinion with most on this board how CYDY is progressing but yet you are invested in the same stock suggesting much lower pps opportunities. Yes they probably paid for the coverage. That's absolutely a must for a breakthrough technology to do this. Absolutely normal to pay a top reptable research coverage to get your story out but only when you have data to back it up. It's disruptive and CYDY needs to get the science to the peers for validation. This is a catalyst for it. As for the ASM "disastrous" they were selected and peer selected over everyone else. I remember qualcomm $3, silicon investor posters from nokia, erickson etc all knocking CDMA on the msg board. Stop and take look at your phone now. Glad I held on. I see the same play here. CYDY is disruptive to whats currently available for HIV treatment. Maybe you should direct your concerns to the FDA that's validating these results and allowing further research or maybethe equity research firm. I respect Drs/scientists have to be skeptics always asking why but to overlook the phase trial extensions is far to skeptic. As for the PPS today, it's against SEC for CYDY to post this on their web. It's a holiday week end coming, vol was low meaning word has not spread yet. Give it a week and I hope you re-think your potential investment here. I won't get into Lupus and HIV but read some of the past results of patients on Pro 140. Finally, call Charlie and ask him how he feels vs his previous treatments. To have someone in a trial in just a few months speaking of the benefits vs competition is huge. Trials are usually so private. Thank you Charlie!.
Chump
